0001549084-23-000059.txt : 20230818 0001549084-23-000059.hdr.sgml : 20230818 20230818162904 ACCESSION NUMBER: 0001549084-23-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230817 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 231186184 BUSINESS ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 8-K 1 ekso-20230817.htm 8-K ekso-20230817
0001549084false00015490842023-08-172023-08-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

August 17, 2023
Date of Report (date of earliest event reported)

Ekso Bionics Holdings, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-3785499-0367049
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
101 Glacier Point, Suite A
San Rafael
California
94901
(Address of Principal Executive Offices)
(Zip Code)
(510) 984-1761
Registrant's telephone number, including area code

Not Applicable
________________________
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareEKSO
Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o



Item 1.01 Entry Into A Material Definitive Agreement.

On August 17, 2023, Ekso Bionics Holdings, Inc. (the “Company”), Ekso Bionics, Inc., the Company’s wholly owned subsidiary (“Ekso Bionics” and, together with the Company, the “Borrower”) and Pacific Western Bank (the “Lender”), entered into the Fifth Amendment to Loan and Security Agreement (the “Amendment”). Unless otherwise indicated, the terms used below have the meanings ascribed in the Amendment.

The Amendment amends that certain Loan and Security Agreement dated as of August 13, 2020, by and between the Borrower and the Lender to, among other things, (i) have daily borrowings under the Term Loan bear interest at a variable annual rate equal to the greater of (A) the Lender’s “prime rate” then in effect and (B) 4.50%, (ii) cause the Borrower to maintain all of its depository, operating, and investment accounts with Lender and (iii) extend the Term Loan Maturity Date to August 13, 2026.

This description of the Amendment is only a summary thereof and is qualified in its entirety by reference to the copy of the Amendment, which is filed as Exhibit 10.1 to this current report on Form 8-K and incorporated herein by reference.


Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information included in Item 1.01 above is incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.





SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 


EKSO BIONICS HOLDINGS, INC.

By:    /s/ Jerome Wong        
Name:    Jerome Wong
Title:    Chief Financial Officer

Dated: August 18, 2023

EX-10.1 2 ex101-5thamendment.htm EX-10.1 Document

FIFTH AMENDMENT
TO
LOAN AND SECURITY AGREEMENT
This Fifth Amendment to Loan and Security Agreement (the “Amendment”), is entered into as of August 17, 2023, by and among PACIFIC WESTERN BANK, a California state-chartered bank (the “Bank”), EKSO BIONICS, INC., and EKSO BIONICS HOLDINGS, INC. (individually and collectively referred to as “Borrower”).
RECITALS
Borrower and Bank are parties to that certain Loan and Security Agreement dated as of August 17, 2020 (as amended from time to time, the “Agreement”). The parties desire to amend the Agreement in accordance with the terms of this Amendment.
NOW, THEREFORE, the parties agree as follows:
1)Section 2.3(a)(i) of the Agreement is hereby amended and restated as follows:
(i)Term Loan. Except as set forth in Section 2.3(b), the Term Loan shall bear interest, on the outstanding daily balance thereof, at a variable annual rate equal to the greater of: (A) the Prime Rate then in effect; or (B) 4.50%.
2)Section 6.6 of the Agreement is hereby amended and restated as follows:
6.6     Primary Depository. Beginning on the date occurring 30 days after the Fifth Amendment Date and continuing at all times thereafter, Borrower shall maintain, and shall cause all of its Subsidiaries to maintain, all depository, operating, and investment accounts with Bank. On or before the date occurring 30 days after the Fifth Amendment Date, Borrower shall deliver evidence satisfactory to Bank that Borrower has closed its account(s) at JPMorgan Chase. Notwithstanding the foregoing, Borrower’s Subsidiaries domiciled outside the United States may maintain up to an aggregate of $1,000,000 (or its USD equivalent) in accounts outside of Bank.
3)The following definition is hereby added (in alphabetical order) to Exhibit A to the Agreement, as follows:
        “Fifth Amendment Date” means August 17, 2023.
4)The following term and its definition are hereby amended and restated in Exhibit A to the Agreement, as follows:
    “Term Loan Maturity Date” means August 13, 2026.
5)No course of dealing on the part of Bank or its officers, nor any failure or delay in the exercise of any right by Bank, shall operate as a waiver thereof, and any single or partial exercise of any such right shall not preclude any later exercise of any such right. Bank's failure at any time to require strict performance by Borrower of any provision shall not affect any right of Bank thereafter to demand strict compliance and performance. Any suspension or waiver of a right must be in writing signed by an officer of Bank.
6)Unless otherwise defined, all initially capitalized terms in this Amendment shall be as defined in the Agreement. The Agreement, as amended hereby, shall be and remain in full force and effect in accordance with its respective terms and hereby is ratified and confirmed in all respects. Except as expressly set forth herein, the execution, delivery, and performance of this Amendment shall not operate as a waiver of, or as an amendment of, any right, power, or remedy of Bank under the Agreement, as in effect prior to the date hereof. Borrower



ratifies and reaffirms the continuing effectiveness of all agreements entered into in connection with the Agreement.
7)Each Borrower represents and warrants that the representations and warranties contained in the Agreement are true and correct as of the date of this Amendment, and that no Event of Default has occurred and is continuing.
8)This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Amendment. Executed copies of this Amendment or the signature pages of this Amendment sent by facsimile or transmitted electronically in Portable Document Format (“PDF”) or any similar format, or transmitted electronically by digital image, DocuSign, or other means of electronic transmission, shall be treated as originals, fully binding and with full legal force and effect, and the parties waive any rights they may have to object to such treatment. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this Amendment and/or any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include Electronic Signatures (as defined below), deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be. As used herein, “Electronic Signatures” means any electronic symbol or process attached to, or associated with, any contract or other record and adopted by a person with the intent to sign, authenticate or accept such contract or record.
9)As a condition to the effectiveness of this Amendment, Bank shall have received, in form and substance satisfactory to Bank, the following:
a)this Amendment, duly executed by Borrower;
b)an officer’s certificate of Borrower with respect to incumbency and resolutions authorizing the execution and delivery of this Amendment;
c)payment of a $2,000 facility fee, which may be debited from any of Borrower’s accounts at Bank;
d)payment of all Bank Expenses, including Bank’s expenses for the documentation of this amendment and any related documents, and any UCC, good standing or intellectual property search or filing fees, which may be debited from any of Borrower's accounts; and
e)such other documents and completion of such other matters, as Bank may reasonably deem necessary or appropriate.
[Signatures appear on the following page.]




IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the first date above written.
EKSO BIONICS, INC.PACIFIC WESTERN BANK
By:     /s/ Jerome Wong                    
Name: Jerome Wong
Title: CFO & Corporate Secretary
By:     /s/ Steve Kent                
Name: Steve Kent
Title: Vice President
EKSO BIONICS HOLDINGS, INC.
By:     /s/ Jerome Wong                    
Name: Jerome Wong
Title: CFO & Corporate Secretary


EX-101.SCH 3 ekso-20230817.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ekso-20230817_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Tax Identification Number Entity Tax Identification Number Entity Central Index Key Entity Central Index Key Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 ekso-20230817_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information Document
Aug. 17, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 17, 2023
Entity Registrant Name Ekso Bionics Holdings, Inc.
Entity Central Index Key 0001549084
Amendment Flag false
Entity Incorporation, State or Country Code NV
Entity File Number 001-37854
Entity Tax Identification Number 99-0367049
Entity Address, Address Line One 101 Glacier Point, Suite A
Entity Address, City or Town San Rafael
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94901
City Area Code 510
Local Phone Number 984-1761
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol EKSO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 ekso-20230817_htm.xml IDEA: XBRL DOCUMENT 0001549084 2023-08-17 2023-08-17 0001549084 false 8-K 2023-08-17 Ekso Bionics Holdings, Inc. NV 001-37854 99-0367049 101 Glacier Point, Suite A San Rafael CA 94901 510 984-1761 false false false false Common Stock, $0.001 par value per share EKSO NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( **#$E<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "B@Q)7Z-8'X.X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R'%@=";-I:.G#@8K;.QF;+4UBQUC:R1]^R5>FS*V!]C1TN]/ MGT"-#E+W$9]C'S"2Q70WNLXGJ<.:G8B"!$CZA$ZE,1@M(? MZH@@.+\'AZ2,(@4SL @+D;6-T5)'5-3'"][H!1\^8Y=A1@-VZ-!3@JJL@+7S MQ' >NP9N@!E&&%WZ+J!9B+GZ)S9W@%V28[)+:AB&GW4M>M[ ^ MD?(:IU_)2CH'7+/KY-=Z\[C?LE9P41=\552KO>!2/$@NWF?7'WXW8=<;>[#_ MV/@JV#;PZR[:+U!+ P04 " "B@Q)7F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M **#$E=+YCOA700 *\0 8 >&PO=V]R:W-H965T&UL MI9C;;N,V$(9?A5"+H@622)3/J6W <9+=(+N)&Z>[0(M>T!)M$Y%(+4G9R=MW M*#N2NRN/#/0FUFE^?9H9_2-FN%7ZQ:PYM^0U3:09>6MKLTO?-]&:I\Q*ARFPC)9YJ8/$V9?KOB MB=J./.J]'W@2J[5U!_SQ,&,K/N?VSVRF8<\O56*1W/O, 1\81'UDDP^-GP*4\2IP0VV M1Z+<6)7N@X$@%7+WRU[WB3@,H$<"PGU 6'#O;E107C/+QD.MMD2[JT'-;12/ M6D0#G)"N*G.KX:R .#N^5E$.2;:$R9C<2"OL&[F3NVJ[K+V?'_H6[N9B_&BO M?+53#H\H3_+5!:&],Q(&8>N_X3Y EJ1A21H6>JTC>E.UX9K\/5D8JZ&6_]01 M[13:]0JNP2]-QB(^\J"##=<;[HU_^8EV@]\1OE;)U\+4JTP^OV6\#@X/[Y_? M(Q#M$J)]&L2,:Z%<16,"?5'+@RN5Y6NJ7Z=$ZZ""^^9ZXBOA*@B,#RRM!6O0 M>3&*7$%OBLB0CRJ)A5R9,VC:Z *A[):4W5,HIY!#S1)0C?DKN>=O=9RX4A $ MM-,>!/TV@M4KL7IX-:"H<5'8VX2MZF#P^"5+#$8/TJ;BVLKCXPQ>$<% 2#DXAO!4))P]YNN"Z#@37@,J=MWK] M#E8Y&E0.&YQ"],Q>R5T,)11+$>W,]3A?@^1@.KV MH &?U5;6TN)R^'S.M-D)&]0G%-:=HXJKY0'%; M_QYMIHP%G_M+9$=?V@;% 7@;G$:2'P_NU^PZ#D0GN\[A< M'JD?KM=$%E8#(,3=^@>R.V-R(&L";)!M!*S\/\3-^EE8F)9J26CXZ^(W,N=1 M#OU6^\W3H.3Z$P;;W*KHY8S\'%S *"49TV3#DIR3#![7K)E&L0\6!+AK/VOF M/O[(_"U=J-KF:Q"XN9\_8B25X8>X.;]GC-R\1FLF5_SHMVV#T,-D?CWY V.J MG#X\R>EO4JY7+DL?0,&NG8-D3-;7%A<\VF_^P?+3+>4_,W='0Q*^!*'@H@>N MK7>KX]V.55FQ(ETH"^O;8G/-&;P+[@(XOU3*ON^X16[Y/XKQOU!+ P04 M" "B@Q)7GZ ;\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK M6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9) ML;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2 MVSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK= M5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>6 M5Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEU MXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z M6PEY7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$// M\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?# M$T%^@2O&+(=/EB>N$_N MG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"= MXI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C% M^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2='@//GL?)=-[*CG_ M5U/\!%!+ P04 " "B@Q)7EXJ[', 3 @ "P %]R96QS+RYR96QS MG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2 MW!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N M&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,E MC'%BM/XU@LD/['X 4$L#!!0 ( **#$E<<.&7J/P$ #P" / >&PO M=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0JA:5BON2=8C%/B*O M RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6I;(&;])-;"#(I(KD M#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$[( =PCG]SKM6G3#A M'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z,@QV0(SE'WC;B?PT M^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,PS/%ML%PZ&C$179E MH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*/:XH$ZQZ#"PAJ748 MJ&2WEYIK=WDWM) MJ'7N0;#W\!J-'[IFBG#S^0W1UW6E\./VR M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/ M3K3G>1,)KM\,<'AT_@%02P,$% @ HH,25V60>9(9 0 SP, M !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V + M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5 M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:> M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/] M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 M" "B@Q)7!T%-8H$ "Q $ @ $ 9&]C4')O<',O M87!P+GAM;%!+ 0(4 Q0 ( **#$E?HU@?@[@ "L" 1 M " :\ !D;V-097)PC M$ 8 )PG 3 " &UL M4$L! A0#% @ HH,25TOF.^%=! KQ !@ ("!#0@ M 'AL+W=O?H!OP ML0( .(, - " : , !X;"]S='EL97,N>&UL4$L! A0# M% @ HH,25Y>*NQS $P( L ( !? \ %]R96QS M+RYR96QS4$L! A0#% @ HH,25QPX9>H_ 0 / ( \ M ( !91 'AL+W=O7!E&UL4$L%!@ ) D /@( 4 ! $! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Document Sheet http://www.eksobionics.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports ekso-20230817.htm ekso-20230817.xsd ekso-20230817_lab.xml ekso-20230817_pre.xml ex101-5thamendment.htm http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ekso-20230817.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "ekso-20230817.htm" ] }, "labelLink": { "local": [ "ekso-20230817_lab.xml" ] }, "presentationLink": { "local": [ "ekso-20230817_pre.xml" ] }, "schema": { "local": [ "ekso-20230817.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ekso", "nsuri": "http://www.eksobionics.com/20230817", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ekso-20230817.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document and Entity Information Document", "menuCat": "Cover", "order": "1", "role": "http://www.eksobionics.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ekso-20230817.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001549084-23-000059-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001549084-23-000059-xbrl.zip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�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end